Latest Reported Offering
$50,000
Target Amount
$1,235,000
Maximum Amount
2027-04-30
Deadline
Security Details
Type: Other
Price per share: $1.00
Price set by: Pro-rated portion of the total principal value of $50,000; interests will be sold in increments of $1; each investment is convertible to one share of stock as described under Item 13.
Shares offered: 50,000+
Offering Costs
Cash commission: 6.9%
of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: —
No
Filing history
Form C family — 1 filing| Filed | Form | File number | Portal | What it states | What the filer said |
|---|---|---|---|---|---|
| 2026-08-17 | C | 020-37342 | Wefunder | $50K target, up to $1.2M · Simple Agreement for Future Equity (SAFE) at $1.00 · closes 2027-04-30 | — |
The reported figures behind The After Cancer Corporation
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
DE
Date of Incorporation
2023-07-18
Latest Metrics
Employees2
Total Assets$89,533
Cash on Hand$42,578
Revenues$105,644
Net Income-$287,325
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.